{
  "node_id": "canada-food-drug-regulations-division-5-clinical-trials",
  "title": "Food and Drug Regulations Part C Division 5 - Clinical Trials",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.1",
  "last_updated": "2026-04-30",
  "bluf": "This regulation requires clinical trial sponsors to submit a Clinical Trial Application (CTA) to Health Canada, as outlined in Section…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "iso_standard",
      "industry_mapping"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "ich-gcp-e6-r3-2023",
    "iso-13485-qms"
  ],
  "primary_citations_count": 5,
  "workflow_steps_count": 6,
  "schema_fields_count": 6,
  "citation_preview": [
    "Food and Drug Regulations, Section C.05.005 - Clinical Trial Application",
    "Food and Drug Regulations, Section C.05.010 - No Objection Letter"
  ]
}